CAM2032 prostate cancer

Camurus’ CAM2032 is a long-acting formulation of leuprolide which features both fast onset and prolonged release of leuprolide acetate. The product, which initially is developed for long term treatment of prostate cancer, is based on Camurus’ proprietary FluidCrystal® injection depot technology and have been designed for simple and convenient administration, also by patients themselves, by a prefilled syringe with a …

CAM2038 chronic pain

CAM2038 is a subcutaneous injection depot of buprenorphine for simple and safe administration by a prefilled syringe. Besides treatment of opiod dependence, CAM2038 once weekly (q1w) and once monthly (q4w) are developed for treatment of chronic pain. Initially, the products will be used to treat opioid experienced patients, but product variants for opioid naive patients are also being developed. CAM2038 …

episil® oral liquid

episil® oral liquid is a lipid-based fluid developed for the management and relief of pain associated with oral lesions of various aetiologies such as oral mucositis, a painful side effect of cancer therapies. After administration, and in contact with small quantities of saliva present in the oral cavity, the lipid mixture self-assembles to form a robust protective lipid membrane that …